ProQR Therapeutics (PRQR) Long-Term Investments (2021 - 2022)
ProQR Therapeutics' Long-Term Investments history spans 2 years, with the latest figure at $633573.6 for Q4 2022.
- For Q4 2022, Long-Term Investments rose 6822.96% year-over-year to $633573.6; the TTM value through Dec 2022 reached $633573.6, up 6822.96%, while the annual FY2022 figure was $654506.6, 6813.43% up from the prior year.
- Long-Term Investments for Q4 2022 was $633573.6 at ProQR Therapeutics, up from $9151.8 in the prior quarter.
- Across five years, Long-Term Investments topped out at $633573.6 in Q4 2022 and bottomed at $9151.8 in Q4 2021.